VXA-CoV2-1

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameVXA-CoV2-1

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaxart Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVaxart Inc

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

ATC CodeN/A